Susan E Waltz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Genes

Science advances

Oncogene

Molecular cancer research : MCR

University of Cincinnati College of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cincinnati College of Medicine

United States

Professor :: Cancer Biology

Cincinnati Children's Research Foundation

United States

Assistant Professor :: Developmental Biology/Basic Science

Publications

James C Davis, Susan E Waltz
The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 15 (7) (2024)
James C Davis, Susan E Waltz
The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 15 (7) (2024)
James C Davis, Susan E Waltz
The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 15 (7) (2024)
James C Davis, Susan E Waltz
The MET Family of Receptor Tyrosine Kinases Promotes a Shift to Pro-Tumor Metabolism. Genes 15 (7) (2024)
Elena Oropeza, Sinem Seker, Sabrina Carrel, Aloran Mazumder, Daniel A Lozano, Athena Jimenez, Sabrina N VandenHeuvel, Dillon A Noltensmeyer, Nindo B Punturi, Jonathan T Lei, Bora Lim, Susan E Waltz, Shreya A Raghavan, Matthew N Bainbridge, Svasti Haricharan
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Science advances 9 (26) (2023)
Brian G Hunt, James C Davis, Levi H Fox, Sara Vicente-Muñoz, Carissa Lester, Susanne I Wells, Susan E Waltz
RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Oncogene (2023)
Brian G Hunt, Levi H Fox, James C Davis, Angelle Jones, Zhixin Lu, Susan E Waltz
An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes 14 (2) (2023)
Elena Oropeza, Sinem Seker, Sabrina Carrel, Aloran Mazumder, Daniel A Lozano, Athena Jimenez, Sabrina N VandenHeuvel, Dillon A Noltensmeyer, Nindo B Punturi, Jonathan T Lei, Bora Lim, Susan E Waltz, Shreya A Raghavan, Matthew N Bainbridge, Svasti Haricharan
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Science advances 9 (26) (2023)
Elena Oropeza, Sinem Seker, Sabrina Carrel, Aloran Mazumder, Daniel A Lozano, Athena Jimenez, Sabrina N VandenHeuvel, Dillon A Noltensmeyer, Nindo B Punturi, Jonathan T Lei, Bora Lim, Susan E Waltz, Shreya A Raghavan, Matthew N Bainbridge, Svasti Haricharan
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Science advances 9 (26) (2023)
Brian G Hunt, Levi H Fox, James C Davis, Angelle Jones, Zhixin Lu, Susan E Waltz
An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes 14 (2) (2023)
Brian G Hunt, Levi H Fox, James C Davis, Angelle Jones, Zhixin Lu, Susan E Waltz
An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes 14 (2) (2023)
Brian G Hunt, Levi H Fox, James C Davis, Angelle Jones, Zhixin Lu, Susan E Waltz
An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes 14 (2) (2023)
Nicholas E Brown, Angelle Jones, Brian G Hunt, Susan E Waltz
Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling. The Prostate 82 (15) (2022)
Brian G Hunt, Angelle Jones, Carissa Lester, James C Davis, Nancy M Benight, Susan E Waltz
RON ( MST1R ) and HGFL ( MST1 ) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers 14 (10) (2022)
Sasha J Ruiz-Torres, Jennifer R Bourn, Nancy M Benight, Brian G Hunt, Carissa Lester, Susan E Waltz
Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene (2021)
Camille D Sullivan, Nicholas E Brown, Juozas Vasiliauskas, Peterson Pathrose, Sandra L Starnes, Susan E Waltz
Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression. Molecular cancer research : MCR 18 (8) (2020)
Brian G Hunt, Christina A Wicker, Jennifer R Bourn, Elyse E Lower, Vinita Takiar, Susan E Waltz
MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients. Breast cancer research and treatment 181 (3) (2020)
Zilan Zhou, Mina Jafari, Vishnu Sriram, Jinsoo Kim, Joo-Youp Lee, Sasha J Ruiz-Torres, Susan E Waltz
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. Molecular pharmaceutics 14 (12) (2017)

Susan E Waltz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Susan E Waltz